Take Action


Filter By:
“Appeals court upholds nearly 30% payment cut to 340B hospitals”
July 1, 2020
Fierce Healthcare
“Congress Has no Clue About What’s Driving up Drug Prices”
June 4, 2020
“Hospitals Are Gaming the 340B Drug Program”
May 21, 2020
“Hospitals serving vulnerable communities chase profits at the expense of patients”
February 27, 2020
The WasteWatcher
“Lax oversight causing drugmakers to dish out duplicate 340B, Medicaid discounts, GAO finds”
January 29, 2020
Becker’s Hospital Review
“GAO: Feds have to improve oversight to stop drug companies from doling out duplicate 340B, Medicaid discounts”
January 28, 2020
Fierce Healthcare
IN CASE YOU MISSED IT: New Study Finds Hospitals Charge Nearly Two Times More Than Physician Offices for Same Cancer Treatments

New research from the Employee Benefit Research Institute (EBRI) has concluded that payments from private third-party payers for infused cancer medicines are, on average, twice as much when care is provided in hospital outpatient departments (HOPDs) compared with physician offices (POs).

January 22, 2020
IN CASE YOU MISSED IT: New GAO Report Finds Oversight Lacking For 340B Hospitals

A new report from the Government Accountability Office (GAO) has concluded increased oversight is needed to ensure nongovernmental hospitals meet 340B eligibility requirements.

January 15, 2020